As of November 2024, Oncternal Therapeutics has a market cap of $4.88M. This makes Oncternal Therapeutics the world's 34577th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $27.20M | -14.91% |
2023 | $31.97M | -46.00% |
2022 | $59.19M | -55.95% |
2021 | $134.37M | -53.67% |
2020 | $290.05M | 24.05% |
2019 | $233.82M | -27.66% |
2018 | $323.20M | -93.86% |
2017 | $5.27B | 140.72% |
2016 | $2.19B | -24.57% |
2015 | $2.90B | -4.11% |
2014 | $3.02B | 784.85% |
2013 | $341.85M | -60.71% |
2012 | $870.16M | 25.00% |
2011 | $696.13M | 26.79% |
2010 | $549.03M | -36.90% |
2009 | $870.16M | -75.06% |
2008 | $3.49B | 17.35% |
2007 | $2.97B | -19.56% |
2006 | $3.70B | 135.98% |
2005 | $1.57B | -43.96% |
2004 | $2.79B | - |